Advertisement

Erkrankungen im Kindesalter

  • Stefan Burdach
  • Peter Groneck
  • Uwe Prelss
  • Michael J. Lentze
  • Ania C. Muntau
  • Uwe Preiss
  • Wieland Kiess
  • Gerd Horneff
  • Ralph Grabitz
  • Rosemarie Schobess
  • Matthias Brandis
  • Rudole Korinthenberg
  • Frank Rauch
  • Eckhard Schönau
  • Lothar Schweigerer
  • Dietmar Schranz
  • Gerhard Jorch
  • Hans-Gerd Lenard
  • Joachim Boos
  • Beate Herpertz-Dahlmann
  • Klaus Mohnike

Zusammenfassung

Bei Entbindungen ohne prä- oder perinatale Risikofaktoren sind in der Regel für das Neugeborene keine Probleme zu erwarten. Trotzdem muss der verantwortliche Arzt einer geburtshilflichen Abteilung dafür Sorge tragen, dass bei jeder Geburt eine Person sofort erreichbar sein kann, die mit den Grundregeln der Reanimation von Neugeborenen vertraut ist. Ein neonatologisch versierter Pädiater sollte bei Risikoentbindungen zugegen sein. Notwendige Ausrüstungen (Reanimationsplatz mit Wärmestrahler, Absaugvorrichtung, Sauerstoff, Beatmungsbeutel, Laryngoskop, Tuben etc.) müssen vorhanden sein und ihre Funktion regelmäßig überprüft werden. Hochrisikoentbindungen sollten in einem Perinatalzentrum erfolgen.

Literatur

  1. American Academy of Pediatrics (1995) Management of hyper- bilirubinemia in the healthy term newborn. Pediatrics 95: 459Google Scholar
  2. Avery ME, Mead J (1959) Surface properties in relation to ate- lectasis and hyaline membrane disease. Am J Dis Child 97: 517–523Google Scholar
  3. Avery GB, Fletcher MA, MacDonald MG (1999) Neonatology. Lippincott-Raven, PhiladelphiaGoogle Scholar
  4. Cloherty JP, Stark AR (1997) Manual of neonatal care. Lippincott-Raven, PhiladelphiaNational Institute of childhealth an human development. www.nichd.nih.gov Google Scholar
  5. Obladen M (1995) Neugeborenen-Intensivpflege. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  6. Remington J, Klein J (1999) Infectious diseases in the fetus and newborn. Saunders, PhiladelphiaGoogle Scholar
  7. Robertson B, Halliday HL (1998) Principles of surfactant replacement. Biochim Biophys Acta 1408: 346–361PubMedCrossRefGoogle Scholar
  8. Sinclair JC, Bracken MB (1992) Effective care of the newborn infant, Oxford University PressGoogle Scholar
  9. Speer CP, Halliday HL (1994) Surfactant therapy in the newborn. Curr Paediatr 4: 5–9CrossRefGoogle Scholar
  10. Taeusch W, Ballard RA (1998) Avery’s diseases of the newborn. Saunders, PhiladelphiaGoogle Scholar
  11. Volpe J (1994) Neurology of the newborn. Saunders, PhiladelphiaGoogle Scholar
  12. Altemeyer KH, Böhles H, Bürger K, Paust H, Pohlandt F, Schröder H, Widhalm K (1987) DAKE (Deutsche Arbeitsgemeinschaft für künstliche Ernährung): Empfehlungen zur parenteralen Infusions-und Ernährungstherapie im Kindesalter. Infusionstherapie 14: 41–44Google Scholar
  13. Ellrot T, Pudel V (1998) Adipositastherapie. Aktuelle Perspektiven. Thieme, StuttgartGoogle Scholar
  14. Herpertz-Dahlmann B, Remschmidt H (1994) Anorexia und Buli-mia nervosa im Jugendalter. Dtsch Ärztebl 91: Al210-Al218Google Scholar
  15. Hoepffner W (Hrsg) (2000) Pädiatrie in Schlagworten. Johann Ambrosius Barth, HeidelbergGoogle Scholar
  16. Michail S, Vanderhoof JA (1996) Parenterale Ernährung in der klinischen Praxis. Annales Nestlé 54: 63–71Google Scholar
  17. Niggemann B, Wahn U (1999) Allergien gegen Nahrungsmittel. In: Wahn U, Seger R, Wahn V (Hrsg) Pädiatrische Allergologie und Immunologie. Urban * Fischer, München; S 331–336Google Scholar
  18. Sandström B, Cederblad A, Lindblad BS, Lönnerdal B (1994) Acrodermatitis enteropathica, zinc metabolism, copper status, and immune function. Arch Pediatr Adolesc Med 148: 980–985PubMedCrossRefGoogle Scholar
  19. Worley G, Claerhout SJ, Combs SP (1998) Hypophosphatemia in malnourished children during refeeding. Clin Pediatr 37: 347–352CrossRefGoogle Scholar
  20. Zwiauer K, Wabitsch M (1997) Relativer Body-mass-Index ( BMI) zur Beurteilung von Übergewicht und Adipositas im Kindes-und Jugendalter. Monatsschr Kinderheilkd 145: 1312–1318Google Scholar
  21. Geißler W, Frigo E, Löbl M, Pumberger W, Wurnig P, Horcher E, Rokitansky A (1997) Problematik der Ösophagusverätzungen. Päd–Praktische Pädiatrie 3: 20–26Google Scholar
  22. Gomes H, Menanteau B (1991) Gastro-esophageal reflux: comparative study between sonography and pH monitoring. Pediatr Radiol 21: 168–174PubMedCrossRefGoogle Scholar
  23. Goriup U, Keller KM, Koletzko B, Lentze M, Stern M (1994) Therapie akuter Durchfallerkrankungen bei Kindern. Monatsschr Kinderheilkd 142: 126–130Google Scholar
  24. Goulet O, Brousse N, Canioni D, Walker-Smith JA, Schmitz J, Philips AD (1998) Syndrome of intractable diarrhea with persistent villous atrophy in early childhood: a clinicopathological survey of 47 cases. J Pediatr Gastroenterol Nutr 26: 151–161PubMedCrossRefGoogle Scholar
  25. Herzog D, Atkinson P, Grant D, Paradis K, Wiliams S, Seiman E (1996) Combined bowel-liver transplantation in an infant with microvillous inclusion disease. J Pediatr Gastroenterol Nutr 22: 405–408PubMedCrossRefGoogle Scholar
  26. Koletzko S (2001) Helicobacter-pylori-Infektion im Kindes-und Jugendalter. Monatsschr Kinderheilkd 149: 588–592CrossRefGoogle Scholar
  27. Loening-Baucke V (1995) Functional constipation. Sem Pediatr Surg 4: 26–34Google Scholar
  28. Online Mendelian Inheritance of Man (OMIM): Datenbank des NIH und NLM unter http://wwwncbi.nlm.nih.gov/OMIMGoogle Scholar
  29. Philips A, Schmitz J (1992) Familial microvillous atrophy: a clinicopathological survey of 23 cases. J Pediatr Gastroenterol Nutr 14: 380–396CrossRefGoogle Scholar
  30. Schuppan D, Dieterich W, Riecken EO (1998) Exposing gliadin as a tasty food for lymphocytes. Nature Med 4: 666–667PubMedCrossRefGoogle Scholar
  31. Wright N, Scott BB (1997) Dietary treatment of active Crohn’s disease. Brit Med J 314: 454–455PubMedCrossRefGoogle Scholar
  32. Wyllie R, Sarigol S (1998) The treatment of inflammatory bowel disease in children. Clin Pediatr 37: 421–426CrossRefGoogle Scholar
  33. IGastroösophagealer Reflux, ReBuzöaophagitís I’rokinetikâ Ramitidin 4,Omeprasol 1Fre~pdkörperingestioa undGoogle Scholar
  34. Leonard JV (1995) The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis 18: 430–434PubMedCrossRefGoogle Scholar
  35. Leonard JV (1995) Urea cycle disorders. In: Fernandes J et al. (eds) Inborn metabolic diseases. Springer, Berlin Heidelberg New York Tokyo, p 169Google Scholar
  36. Maestri NE, Hauser ER, Bartolomew D, Brusilow SW (1991) Prospective treatment of urea cycle disorders. J Pediatr 119: 923–928PubMedCrossRefGoogle Scholar
  37. Muntau AC, Beblo S, Koletzko B (2000) Phenylketonurie und Hy perphenylalaninämie. Monatsschr Kinderheilkd 148: 179–193CrossRefGoogle Scholar
  38. Wanders RJ, Vreken P, den Boer ME, Wijburg FA, van Gennip AH, Ijlst L (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis; 22: 442–487PubMedCrossRefGoogle Scholar
  39. Hoepffner W (Hrsg) (2000) Pädiatrie in Schlagworten, Handbuch der Diagnostik und Therapie, 2. Aufl. Johann Ambrosius Barth, HeidelbergGoogle Scholar
  40. ISPAD (2000) Consensus Guidelines. Medical Forum International Zeist, NetherlandsGoogle Scholar
  41. Kruse K (Hrsg) (1999) Pädiatrische Endokrinologie, 2. Aufl. Georg Thieme, Stuttgart New YorkGoogle Scholar
  42. Bertrand J, Rapaport R, Sizonenko PC (1993) Pediatric Endocrinology, 2° edn Williams * Wilkins, BaltimoreGoogle Scholar
  43. Reinhardt D, Creutzig U, Kiess W, Luthardt T, Michalk D, Schmid E, Ulmer H (Hrsg) (1999) Leitlinien der Deutschen Gesellschaft für Kinderheilkunde und Jugendmedizin, Urban * Fischer, München JenaGoogle Scholar
  44. Bauer TR, Schwartz BR, Conrad-Liles W, Ochs HD, Hickstein DD (1998) Retroviral-mediated gene transfer of the leukocyte integrin CDI8 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 91: 1520–1526PubMedGoogle Scholar
  45. Bux J, Behrens G, Jaeger G, Welte K (1998) Diagnosis and clinical course of autoimmune neutropenia in infancy, analysis of 240 cases. Blood 91: 181–186PubMedGoogle Scholar
  46. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669–672PubMedCrossRefGoogle Scholar
  47. Goring HD, Bork K, Spath PJ, Bauer R, Ziemer A, Hintner H, Wuthrich B (1998) Untersuchungen zum hereditären Angioödem im deutschsprachigen Raum. Hautarzt 49 (2): 114–122PubMedCrossRefGoogle Scholar
  48. Grimbacher B, Holland SM, Gallin JI et al. (1999) Hyper-IgE syndrome with recurrent infections–an autosomal dominant multisystem disorder. N Engl J Med 340 (9): 692–702PubMedCrossRefGoogle Scholar
  49. Matsumoto T, Amamoto N, Kondoh T, Nakayama M, Takayanagi T, Tsuji Y (1998) Complete-type DiGeorge syndrome treated by bone marrow transplantation. Bone Marrow Transplant 22: 927–930PubMedCrossRefGoogle Scholar
  50. Schuster V, Kreth HW (2000) X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Immunol Rew 178: 21–27CrossRefGoogle Scholar
  51. Smart BA, Ochs HD (1997) The molecular basis and treatment of primary immunodeficiency disorders. Curr Opin Pediatr 9: 570–576PubMedCrossRefGoogle Scholar
  52. Weening RS, Leitz GJ, Seger RA (1995) Recombinant human interferon-gamma in patients with chronic granulomatous disease–European follow up study. Eur J Pediatr 154 (4): 295–298PubMedGoogle Scholar
  53. American Academy of Pediatrics, Committee on Infectious Diseases (1992) Chemotherapy for tuberculosis in infants and children. Pediatr 89: 161–165Google Scholar
  54. Horneff G, Wahn V (1998) Antiretroviral treatment of pediatric HIV-infection. Pädiatr Grenzgeb 37: 203–215Google Scholar
  55. Huppertz HI, Karch H, Schuschke HJ et al. (1995) Lyme arthritis in european children and adolescents. Arthritis Rheum 38: 361–368PubMedCrossRefGoogle Scholar
  56. The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from Respiratory Syncytial Virus infection in high-risk infants. Pediatr 102: 531–537Google Scholar
  57. Lai CL, Chien RN, Leung NW et al. (Asia Hepatitis Lamivudine Study Group) (2000) A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 339: 61–68Google Scholar
  58. Rheinhardt D (Hrsg) (2000) Leitlinien Kinderheilkunde und Jugendmedizin, Urban * Fischer, München JenaGoogle Scholar
  59. Whitley RJ, Cloud G, Gruber W et al. (1997) Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study. J Infect Dis 175: 1080–1086Google Scholar
  60. Robert-Koch-Institut (2000) Dtsch Ärzteblatt 16 (Suppl)Google Scholar
  61. Recommended childhood immunization schedule–United States, 2001 (2001) MMWR Morb Mortal Wkly Rep 50: 7–10Google Scholar
  62. Vazquez M, LaRussa PS, Gershon AA et al. (2001) The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 344: 955–960PubMedCrossRefGoogle Scholar
  63. Agertoft L et al. (2000) Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343: 1064–1069PubMedCrossRefGoogle Scholar
  64. Deutsche Gesellschaft für Kinderheilkunde und Jugendmedizin (2001) Leitlinien für Kinderheilkunde. Urban * Fischer, MünchenGoogle Scholar
  65. Rieger C, von der Hardt H, Sennhauser FH, Wahn U, Zach M (1999) Pädiatrische Pneumologie. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  66. The Impact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduce hospitalization, from respiratory syncytial virus infect in high-risk infants. Pediatrics 102: 532–537Google Scholar
  67. Richtlinien zur medikamentösen Behandlung der Tuberkulose im Erwachsenen-und Kindesalter, Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK) Schaberg T, Rotenburg (federführend); Forßbohm M, Wiesbaden; Hauer B, Berlin; Kirsten D, Großhansdorf; Kropp R, Fulda; Loddenkemper R, Berlin; Magdorf K, Berlin; Rieder H, Kirchlindach (Schweiz); Sagebiel D, Berlin; Urbanczik R, Schömberg-Schwarzberg. Pneumologie 2001, 55: 494–551Google Scholar
  68. Alexander ME, Berul CI (2000) Ventricular arrhythmias: when to worry. Pediatr Cardiol 21: 532–541PubMedCrossRefGoogle Scholar
  69. Allen (2000) Moss and Adams’ heart disease in infants, children and adolescents, 6th edn. Williams * Wilkins, PhiladelphiaGoogle Scholar
  70. Apitz J (Hrsg) (1998) Pädiatrische Kardiologie: Erkrankungen des Herzens bei Neugeborenen, Kindern und Heranwachsenden. Steinkopff, DarmstadtGoogle Scholar
  71. Bernuth G von, Toussaint R, Mund C, Rabe P, Timbul K (1989) Herzfrequenz und Herzrhythmus bei gesunden Säuglingen und Kindern. Klin Pädiatr 201 (2): 98–103CrossRefGoogle Scholar
  72. Bink-Boelkens MT (2000) Pharmacologic management of arrhythmias. Pediatr Cardiol 21 (6): 508–515PubMedCrossRefGoogle Scholar
  73. Deutsche Gesellschaft für Pädiatrische Kardiologie (Hrsg) (1998) Leitlinien zur rationellen Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufes bei Kindern und Jugendlichen. Steinkopff, Darmstadt [www.kinderkardiologie.org]Google Scholar
  74. Hausdorf G (2000) Intensivtherapie angeborener Herzfehler. Steinkopff, DarmstadtGoogle Scholar
  75. Martin JM, Neches WH, Wald ER (1997) Infective endocarditis: 35 years of experience at a children’s hospital. Clin Infect Dis 24 (4): 669–675PubMedCrossRefGoogle Scholar
  76. Schmaltz AA (2001) Dilatative Kardiomyopathien im Kindesalter. Z Kardiol 90 (4): 263–268PubMedCrossRefGoogle Scholar
  77. Schumacher G, Hess J, Bühlmeyer K (Hrsg) (2001) Klinische Kinderkardiologie: Diagnostik und Therapie der angeborenen Herzfehler, 3. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  78. Soergel M, Kirschstein M, Busch C et al. (1997) Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. Pediatr 130 (2): 178–184CrossRefGoogle Scholar
  79. Agre P, Asimos A, Casella JF, McMillan C (1986) Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med 315 (25): 1579–83PubMedCrossRefGoogle Scholar
  80. Burdach S, Jurgens H, Peters C, Nurnberger W, Mauz-Korholz C, Korholz D, Paulussen M, Pape H, Dilloo D, Koscielniak E, et al. (1993) Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing’s sarcoma. J Clin Oncol 11 (8): 1482–8PubMedGoogle Scholar
  81. Lucrarelli G, Galimberti M, Polchi P, Giardini C, Politi P, Baron-ciani D, Angelucci E, Manenti F, Delfini C, Aureli G et al. (1987) Marrow transplantation in patients with advanced thalassemia. N Engl J Med 316 (17): 1050–5CrossRefGoogle Scholar
  82. Nathan DG, Orkin SH (1998) Nathan and Oski’s hematology of infancy and childhood, vol 1 * 2. WB Saunders, Philadelphia PizzoGoogle Scholar
  83. PA, Poplack DG (1997) Principles and practice of pediatric oncology. Lippincott-Raven, PhiladelphiaGoogle Scholar
  84. Pollock BH, Krischer JP, Vietti TJ (1991) Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr 119 (5): 725–32PubMedCrossRefGoogle Scholar
  85. Reinhard D (2001) Leitlinien Kinderheilkunde und Jugendmedizin. Urban * Fischer, München JenaGoogle Scholar
  86. Reinhard D (1997) Therapie der Krankheiten im Kindes-und Ju- gendalter. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  87. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zinti F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy. Blood 95 (11): 3310–22PubMedGoogle Scholar
  88. Thomas ED, Blume KG, Forman SJ (1999) Hematopoietic cell transplantation. Blackwell Science, Oxford London EdinburghGoogle Scholar
  89. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan KM (1996) Bone marrow transplantation for sickle cell diseases. N Engl J Med 335 (6): 369–76PubMedCrossRefGoogle Scholar
  90. Andrew M, David M, Adams M et al. (1994) Venous thromboenbolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 83: 1251–1257PubMedGoogle Scholar
  91. Andrew M, Michelson AD, Bovill E, Leaker M, Massicotte MP (1998) Guidelines for antithromboc therapy in pediatric patients. J Pediatr 132: 576–588Google Scholar
  92. Bertina RM, Koelerman BP, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64–67PubMedCrossRefGoogle Scholar
  93. Blanchette V, Imbach P, Andrew M et al. (1994) Randomized trial of intravenous immunoglobin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344: 703–707PubMedCrossRefGoogle Scholar
  94. Ehrenforth S, Kreuz W, Funk M et al. (1994) Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors. Thromb Haemost 72: 782–786Google Scholar
  95. George JN (2000) Initial management of immune thrombocytopenic purpura in children: Is supportive counseling without therapeutic intervention sufficient? J Pediatr 137: 698–699Google Scholar
  96. George JN, Woolf SH, Raskob GE et al. (1996) Review: ITP. A practice guideline developed by explicit methods for the American Society of Hematology. Blood 78: 3–40Google Scholar
  97. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U (1999) Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscl Thromb Vasc Biol 19: 2568–2572PubMedCrossRefGoogle Scholar
  98. Kreuz W, Ehrenforth S, Funk M (1995) Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-up. Haemophilia 1: 24–32CrossRefGoogle Scholar
  99. Lilleyman JS (1999) Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 105: 871–875PubMedCrossRefGoogle Scholar
  100. Mannucci PM (2001) Treatment of von Willebrand disease. Thromb Haemost 86: 149–153PubMedGoogle Scholar
  101. Massicotte MP, Adams M, Marzinotto V, Brooker LA, Andrew M (1999) Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study. J Pediatr 128: 313–318Google Scholar
  102. Medeiros D, Buchanan GR (2000) Idiopathic thrombocytopenic purpura: beyond consensus. Curr Opin Pediatr 12: 4–9PubMedCrossRefGoogle Scholar
  103. Nowak-Göttl U, Kosch A, Schlegel N (2001) Thromboembolism in newborns, infants and children. Thromb Haemost 86: 464–474Google Scholar
  104. Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, Eckardstein A (1999) Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke. Blood 94: 3678–3682PubMedGoogle Scholar
  105. Ruggeri ZM (1999) Structure and function of von Willebrand factor. Thromb Haemost 82: 576–584PubMedGoogle Scholar
  106. Schimpf K (1994) Therapie der Hämophilien. Hämostaseologie 14: 44–54Google Scholar
  107. Schneppenheim R, Thomas KB, Sutor AH (1995) Von Willebrand disease in childhood. Semin Thromb Hemost 21: 261–275PubMedCrossRefGoogle Scholar
  108. Schramm W (1994) Konsensus-Empfehlungen zur Hämophiliebehandlung in Deutschland. Hämostaseologie 14: 81–83Google Scholar
  109. Sutor AH, Gaedicke G (1998) Acute autoimmune thrombocytope- nia (Review) (40 refs). Baillieres Clin Haematol 11: 381–389PubMedCrossRefGoogle Scholar
  110. Sutor AH, Harms A, Kaufmehl K (2001) Acute immune thrombocytopenia (ITP) in childhood. Retrospective and prospective survey in Germany. Sem Thromb Hemostas (in press)Google Scholar
  111. Univar A, Warrier I, Lusher JM (2000) Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors. Haemophilia 6: 150–157CrossRefGoogle Scholar
  112. White GC (2001) Gene therapy in hemophilia: Clinicals trials update. Thromb Haemost 86: 172–177PubMedGoogle Scholar
  113. Aromaa M, Sillanpaa ML, Rautava P, Helenius H (1998) Childhood headache at school entry: a controlled clinical study. Neurology 50: 1729–1736PubMedCrossRefGoogle Scholar
  114. Aicardi J (1994) Epilepsy in children, 2nd edn. Raven, New York Dubowitz V (1995) Muscle disorders in childhood, 2nd edn. Saunders, LondonGoogle Scholar
  115. Gilmartin R, Bruce D, Storrs BB et al. (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15: 71–77PubMedCrossRefGoogle Scholar
  116. Knudsen FU (1996) Febrile seizures–treatment and outcome (review). Brain Dey 18: 438–449CrossRefGoogle Scholar
  117. Mayo NE (1991) The effect of physical therapy for children with motor delay and cerebral palsy. A randomized clinical trial. Am J Phys Med Rehabil 70: 258–267PubMedCrossRefGoogle Scholar
  118. Ottenbacher KJ, Biocca Z, DeCremer G, Gevelinger M, Jedlovec KB, Johnson MB (1986) Quantitative analysis of the effectiveness of pediatric therapy. Emphasis on the neurodevelopmental treatment approach. Phys Ther 66: 1095–1101Google Scholar
  119. Plasma Exchange/Sandoglobulin Guillain-Barré syndrome Trial Group (1997) Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 349: 225–230Google Scholar
  120. Sutherland DH; Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ (1999): Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait * Posture 10: 1–9CrossRefGoogle Scholar
  121. Überall MA, Wenzel D (1999) Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 52, 1507–1510CrossRefGoogle Scholar
  122. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339: 947–952PubMedCrossRefGoogle Scholar
  123. Rauch F, Schönau E, Glorieux FH (2000) Bisphosphonate–Anwendung in der Pädiatrie. Monatsschr Kinderheilkd 148: 334–341CrossRefGoogle Scholar
  124. Shores J, Berger KR, Murphy EA, Pyeritz RE (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 330: 1335–1341PubMedCrossRefGoogle Scholar
  125. Kautz G, Cremer H (1999) Hämangiome. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  126. Mulliken JB, Young AE (1988) Vascular birthmarks. WB Saunders, PhiladelphiaGoogle Scholar
  127. Schweigerer L (1999) Angiogene Krankheiten. In: Nawroth PP, Lasch HG (Hrsg) Vaskuläre Medizin. Uni-Med Verlag, Lorch, S. 161–165Google Scholar
  128. Vikkula M, Boon LM, Mulliken JB, Olsen BR (1998) Molecular basis of vascular anomalies. Trends Cardiovasc Med 8: 281–292PubMedCrossRefGoogle Scholar
  129. American Society for Parental and Enteral Nutrition (ASPEN) (1993) Guidelines for the use of parenteral and enteral nutrition in adults and pediatric patients. J Parenteral Enteral Nutt 17 (Suppl): 1–52Google Scholar
  130. Ashton H (1994) Guidelines for the rational use of benzodiazepines. Drugs 48: 25–40PubMedCrossRefGoogle Scholar
  131. Bissonnette B, Sessler DI, LaFlamme P (1989) Passive and active inspired gas humification in infants and children. Anesthesiology 71: 350–354PubMedCrossRefGoogle Scholar
  132. Cote CJ, Goldstein EA, Cote MA, Hoaglin DC, Ryan JF (1988) A single-blind study of pulse oximetry in children. Anesthesiology 68: 184–188PubMedCrossRefGoogle Scholar
  133. Cote CJ, Rolf N, Liu LMP et al. (1991) A single-blind study of combined pulse oximetry and capnography in children. Anesthesiology 74: 980–987PubMedCrossRefGoogle Scholar
  134. Cote CJ: (1994) Sedation for the pediatric patient. Pediatr Clin North Am 41: 31–58PubMedGoogle Scholar
  135. Gillman MW, Cook NR (1995) Blood pressure measurement in childhood epidemiological studies. Circulation 92: 1049–1057PubMedCrossRefGoogle Scholar
  136. Hickey PR (1992) Transesophageal echocardiography in pediatric cardiac surgery. Anesthesiology 77: 610–611PubMedCrossRefGoogle Scholar
  137. Lake CL (1993) Monitoring of the pediatric cardiac patient. In: Lake CL (ed) Pediatric cardiac anesthesia, 2nd ed. Appelton * Lange, Norwalk/CTGoogle Scholar
  138. Lattanzi WE, Siegel NJ (1986) A practical guide to fluid and electrolyte therapy. Curr Probl Pediatr 16: 1–43PubMedGoogle Scholar
  139. Martin LD, Pasternack LR, Pudimat MA (1992) Total intravenous anesthesia with propofol in pediatric patients outside the operating room. Anesth Analg 74: 609–612PubMedGoogle Scholar
  140. McCracken GH (1992) Current management of bacterial meningitis in infants and children. Pediatr Infect Dis J 11: 702–709CrossRefGoogle Scholar
  141. Michel-Behnke I, Rothes A, Hund F et al. (1995) Analgosedierung mit Fentanyl/Midazolam nach Korrektur angeborener Herzfehler. Klin Pädiatr 207: 341–346PubMedCrossRefGoogle Scholar
  142. Motoyama EK (1995) Respiratory physiology in infants and children. In: Motoyama EK, Davies PJ (eds) Smith’s anesthesia for infants and children, 6th edn. Mosby, St. LouisGoogle Scholar
  143. Nelson JD (1991) Pocketbook of pediatric antimicrobial therapy 9, 2nd ed Williams * Wilkins, BaltimoreGoogle Scholar
  144. Pullerits J (1992) Routine and special pediatric airway equipment. Int Anesthesiol Clin 30: 109–130PubMedGoogle Scholar
  145. Rogers MC (1991) Textbook of pediatric intensive care vol I/II, 2nd ed Williams * Wilkins, Baltimore - London - Los Angeles - SydneyGoogle Scholar
  146. Schranz D (1993) Pädiatrische Intensivtherapie, 2. Aufl. Gustav Fischer, Stuttgart JenaGoogle Scholar
  147. Sieber FE, Smith DS, Traystman RJ, Wollman H (1987) Glucose: a reevalution of ist intraoperative use. Anesthesiology 67: 72–81PubMedCrossRefGoogle Scholar
  148. Yaster M (1987) The dose response of fentanyl in neonatal anes-thesia. Anesthesiology 66: 433–435PubMedCrossRefGoogle Scholar
  149. Yemen TA (1992) Noninvasive monitoring in the pediatric patient, Int Anesthesiol Clin 30: 77–90PubMedGoogle Scholar
  150. Eminson DM, Postlethwaite RJ (eds) (2000) Munchhausen Syndrome by Proxy Abuse: A Practical Approach. Butterworth Heinemann, OxfordGoogle Scholar
  151. Hall DE, Eubanks L, Meyyazhagan LS, Kenny RD, Johnson SC (2000) Evaluation of covert video surveillance in the diagnosis of Munchhausen syndrome by proxy. Pediatrics 105: 1305–1312PubMedCrossRefGoogle Scholar
  152. Helfer ME, Kempe RS, Krugman RA (eds) (1997) The battered child, 5th edn. Univ Press, ChicagoGoogle Scholar
  153. Hobbs CJ, Hanks HG, Wynne JM (1999) Child abuse and neglect: a clinician’s handbook, 2nd edn. Churchill Livingstone, LondonGoogle Scholar
  154. Hobbs CJ, Wynne JM (1996) Physical signs of child abuse. a colour atlas. Saunders, LondonGoogle Scholar
  155. Kleinman PK (1998) Diagnostic imaging of child abuse, 2nd edn. Mosby, St. LouisGoogle Scholar
  156. Meadow R (1997) ABC of child abuse, 3rd edn. BMJ Publishing Group, LondonGoogle Scholar
  157. Reece RM, Ludwig S (eds) (2001) Child Abuse; Medical Diagnosis and Management, 2nd edn. Lippincott Williams * Wilkins, PhiladelphiaGoogle Scholar
  158. Abramowitz AJ (1994) Classroom interventions for disruptive behavior disorders. Child Adolesc Psychiatr Clin North Am 3: 343–360Google Scholar
  159. Anastopoulos AD, Shelton TL, DuPaul GJ, Guevrement DC (1993) Parent training for attention-deficit hyperactivity disorder: its impact on parent functioning. J Abnorm Child Psychol 21: 581–596PubMedCrossRefGoogle Scholar
  160. Daly G, Hawi Z, Fitzgerald M, Gill M (1999) Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DATI, DBH and DADS to affected children. Mol Psychiatry 4: 192–196Google Scholar
  161. Döpfner M, Lehmkuhl G (2000) Hyperkinetische Störungen. In: Leitlinien zu Diagnostik and Therapie von psychischen Störungen im Säuglings-, Kindes-and Jugendalter. Deutscher Arzteverlag, Köln, S 225–236Google Scholar
  162. Goodman R, Stevenson J (1989) A twin study of hyperactivity: I. An examination of hyperactivity scores and categories derived from Rutter Teacher and Parent Questionnaires. II. The aetiological role of genes, family relationships and perinatal adversity. J Child Adolesc Psychiatry 30: 671–710Google Scholar
  163. Greenhill LL, Halperin JM, Abikoff H (1999) Stimulant medications. J Am Acad Child Adolesc Psychiatry 38: 503–512PubMedCrossRefGoogle Scholar
  164. Multimodal-Treatment Study of children with ADHD; MTA Cooperative Group (1999a) A 14-month randomized clinical trial of treatment strategies for attentiondeficit/hyperactivity disorder. Arch Gen Psychiatry 56: 1073–1086Google Scholar
  165. Multimodal-Treatment Study of children with ADHD; MTA Cooperative Group (1999b) Moderators and mediators of treatment response for children with attentiondeficit/hyperactivity disorder. Arch Gen Psychiatry 56: 1088–1096Google Scholar
  166. Quaschner K (1997) Hyperkinetische Störungen. In: Remschmidt H (Hrsg) Psychotherapie im Kindes-and Jugendalter. Thieme, Stuttgart New York, S 343–355Google Scholar
  167. Schachar R, Tannock R (1993) Childhood hyperactivity and psychostimulants: a review of extended treatment studies. J Child Adolesc Psychopharmacol 3: 81–97PubMedCrossRefGoogle Scholar
  168. Taylor E, Sergeant J, Doepfner M, Gunning B, Overmeyer S, Möbius HJ, Eiser HG (1998) Clinical guidelines for hyperkinetic disorder. Eur Child Adolesc Psychiatry 7: 184–200PubMedCrossRefGoogle Scholar
  169. Haverkamp F, Eiholzer U, Ranke MB, Noeker M (2000) Symptomatic versus substitution growth hormone therapy in short children: from auxology towards a comprehensive multidimensional assessment of short stature and related interventions. J Pediatr Endocrinol Metab 13: 403PubMedCrossRefGoogle Scholar
  170. Hintz RL, Attie KM, Baptista J, Roche A (1999) Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med 340: 502PubMedCrossRefGoogle Scholar
  171. Mohnike K, Klingebiel KH, Zabel B (2001) Achondroplasie und Hypochondroplasie. Diagnostik und Betreuung von Kindern mit spezifischen Kleinwuchsformen. Palatium, MannheimGoogle Scholar
  172. Ranke MB, Fahlbusch R, Becker G et al. (2000) Strategien für Kraniopharyngeome im Kindes-und Jugendalter. Kinder-und Jugendarzt 31: 597–601Google Scholar
  173. Ranke MB, Stahnke N, Mohnike K (2000) Diagnostik und Therapie des STH-Mangels bei Kindern und Jugendlichen. Endokrinologie-Informationen 24, 131–134Google Scholar
  174. Root AW (1998) Editorial: Does growth hormone have a role in the management of children with nongrowth hormone deficient short stature and intrauterine growth retardation? J Clin Endocrinol Metab 83: 1067PubMedCrossRefGoogle Scholar
  175. Spranger J (1997) Irrtümer der Skelettentwicklung. Monatsschr Kinderheilkd 145: 334CrossRefGoogle Scholar
  176. Witt DR, Keena BA, Hall JG, Allanson JE (1986) Growth curves for height in Noonan syndrome. Clin Genet 30: 150PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Stefan Burdach
  • Peter Groneck
  • Uwe Prelss
  • Michael J. Lentze
  • Ania C. Muntau
  • Uwe Preiss
  • Wieland Kiess
  • Gerd Horneff
  • Ralph Grabitz
  • Rosemarie Schobess
  • Matthias Brandis
  • Rudole Korinthenberg
  • Frank Rauch
  • Eckhard Schönau
  • Lothar Schweigerer
  • Dietmar Schranz
  • Gerhard Jorch
  • Hans-Gerd Lenard
  • Joachim Boos
  • Beate Herpertz-Dahlmann
  • Klaus Mohnike

There are no affiliations available

Personalised recommendations